Personalis Inc (NAS:PSNL)
$ 5.87 -0.39 (-6.23%) Market Cap: 497.15 Mil Enterprise Value: 431.68 Mil PE Ratio: 0 PB Ratio: 2.49 GF Score: 61/100

Personalis Inc at Morgan Stanley Global Healthcare Conference (Virtual) Transcript

Sep 17, 2020 / 07:30PM GMT
Release Date Price: $23.08 (-1.95%)
Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

I'm Tejas Savant, and I cover the life sciences and diagnostics sector here at Morgan Stanley. Delighted to have Personalis join us today, and representing the company are John West, CEO; and Aaron Tachibana, CFO. Welcome, gents.

Before we get started, I have a quick disclaimer I need to read through. So please note that the webcast is for Morgan Stanley's clients and appropriate Morgan Stanley employees only. The webcast is not for members of the press, so if you're with the press, please disconnect and reach out separately. For important disclosures, please see morganstanley.com/researchdisclosures. And if you have any questions, please reach out to your Morgan Stanley sales rep.

Questions & Answers

Tejas Rajeev Savant
Morgan Stanley, Research Division - Equity Analyst

So with that said, John, welcome once again. Maybe just to set the stage, could you share your perspective on the evolution of Personalis over the last 5 years or so? I mean maybe even before -- I mean,

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot